- Human（2）
No data
- -（1）
- Flag Tag（1）
No data
- HEK293（2）
No data
- Unconjugated（2）
No data
- RUO（2）
No data
- No（2）
No data
- 20ug/$805.00
- 100ug/$2985.00
- 500ug/$7480.00
No data
- 20ug/$620.00
- 100ug/$1235.00
- 500ug (250ug X 2)/$4305.00
No data
| Molecule | Cat. No. | Product Name | Espèce | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| GPR56 | Human GPR56 Full Length Protein (H381S), Flag Tag (Detergent) |  Human | HEK293 | $805.00 20ug |   | ||||
| GPR56 | Human GPR56 Full Length Protein (VLP) | Human | HEK293 | HPLC | $620.00 20ug | |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Mesenchymal stem cells therapy (Therapeutic Solutions International) | Phase 3 Clinical | Jadi Cell LLC | Coronavirus Disease 2019 (COVID-19) | Details | |
| KLS-2031 | KLS-2031 | Phase 2 Clinical | Kolon Life Science. Inc | Radiculopathy | Details |
| WP-1303 (worgpharma) | ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825A | Phase 2 Clinical | Apitope Technology | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Multiple Myeloma | Details |
| Faecalibacterium prausnitzii EXL01 (Exeliom) | EXL-01; EXL01 | Phase 2 Clinical | Exeliom Biosciences | Stomach Neoplasms; Clostridium Infections; Crohn Disease; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Bacterial Infections | Details |
| XT-150 | XT-101; XT-150; XT-101-R | Phase 2 Clinical | Xalud Therapeutics Inc | Multiple Sclerosis; Back Pain; Osteoarthritis, Knee; Neuralgia; Inflammation; Osteoarthritis, Spine; Arthralgia; Amyotrophic Lateral Sclerosis | Details |
| Anti-CD19 IL10 CAR-NK cell therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Second Affiliated Hospital School Of Zhejiang University School Of Medicine | Lymphoma, B-Cell | Details |
